Developmental lineage of cell types in cortical dysplasia with balloon cells

Brain

Volumn 130, Issue 9, 2007, Pages 2267-2276

  Lamparello, Phillip ^a   Baybis, Marianna ^a   Pollard, John ^a   Hol, Elly M ^b   Eisenstat, David D ^c   Aronica, Eleonora ^d   Crino, Peter B ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cortical dysplasia; Development of brain; Epileptology; Molecular genetics

Indexed keywords

ANTICONVULSIVE AGENT; CELL PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 4; LIPID BINDING PROTEIN; PROTEIN DLX1; PROTEIN DLX2; PROTEIN GFAPDELTA; PROTEIN MASHI; PROTEIN OTX1; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; VIMENTIN;

ADOLESCENT; ARTICLE; BRAIN DEVELOPMENT; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGE OF ONSET; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CEREBRAL CORTEX; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NERVE TISSUE PROTEINS; NEURONS; RNA, MESSENGER; STEM CELLS; VESICULAR GLUTAMATE TRANSPORT PROTEINS; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 34548220994     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm175     Document Type: Article

References (55)

1. Acampora D, Gulisano M, Broccoli V, Simeone A. Otx genes in brain morphogenesis. Prog Neurobiol 2001; 64: 69-95.
2. Anderson SA, Eisenstat DD, Shi L, Rubenstein JL. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science 1997; 278: 474-6.
3. Anderson SA, Marin O, Horn C, Jennings K, Rubenstein JL. Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 2001; 128: 353-63.
4. Alonso-Nanclares L, Garbelli R, Sola RG, Pastor J, Tassi L, Spreafico R, et al. Microanatomy of the dysplastic neocortex from epileptic patients. Brain 2005; 128 (Pt 1): 158-73.
5. Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, et al. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 2004; 14: 634-46.
6. Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G 2nd, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004; 56: 478-87.
7. Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, et al. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 2004; 480: 264-80.
8. Calcagnotto ME, Paredes MF, Tihan T, Barbaro NM, Baraban SC. Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 2005; 25: 9649-57.
9. Cepeda C, Hurst RS, Flores-Hernandez J, Hernandez-Echeagaray E, Klapstein GJ, Boylan MK, et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003; 72: 472-86.
10. Cepeda C, Andre VM, Levine MS, Salamon N, Miyata H, Vinters HV, et al. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 2006; 9: 219-35.
11. Cnops L, Hu TT, Burnat K, Van der Gucht E, Arckens L. Age-dependent alterations in CRMP2 and CRMP4 protein expression profiles in cat visual cortex. Brain Res 2006; 1088: 109-19.
12. Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, et al. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 2005; 8: 1059-68.
13. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol 1997; 93: 619-27.
14. Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, Brooks-Kayal AR. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 2002; 43: 211-8.
15. DeRosa MJ, Farrell MA, Burke MM, Secor DL, Vinters HV. An assessment of the proliferative potential of 'balloon cells' in focal cortical resections performed for childhood epilepsy. Neuropathol Appl Neurobiol 1992; 18: 566-74.
16. Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol 2005; 109: 519-33.
17. Fauser S, Huppertz HJ, Bast T, Strobl K, Pantazis G, Altenmueller DM, et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 2006; 129 (Pt 7): 1907-16.
18. Feng L, Hatten ME, Heintz N. Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 1994; 12: 895-908.
19. Frantz GD, Weimann JM, Levin ME, McConnell SK. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J Neurosci 1994; 14: 5725-40.
20. Fujiyama F, Furuta T, Kaneko T. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 2001; 435: 379-87.
21. Garbelli R, Munari C, De Biasi S, Vitellaro-Zuccarello L, Galli C, Bramerio M, et al. Taylor's cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol 1999; 9: 445-61.
22. Gotz M, Stoykova A, Gruss P. Pax6 controls radial glia differentiation in the cerebral cortex. Neuron 1998; 21: 1031-44.
23. Götz M, Sommer L. Cortical development: the art of generating cell diversity. Development 2005; 132: 3327-32.
24. Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, et al. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 2001; 21: RC181.
25. Hevner RF. Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development. J Neuropathol Exp Neurol 2007; 66: 101-9.
26. Hevner RF, Daza RA, Rubenstein JL, Stunnenberg H, Olavarria JF, Englund C. Beyond laminar fate: toward a molecular classification of cortical projection/pyramidal neurons. Dev Neurosci 2003; 25: 139-51.
27. Howard B, Chen Y, Zecevic N. Cortical progenitor cells in the developing human telencephalon. Glia 2006; 53: 57-66.
28. Kee NJ, Preston E, Wojtowicz JM. Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. Exp Brain Res 2001; 136: 313-20.
29. Kyin R, Hua Y, Baybis M, Scheithauer B, Kolson D, Uhlmann E, Gutmann D, Crino PB. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. Amer J Pathol 2001; 159: 1541-54.
30. Lee A, Maldonado M, Baybis M, Walsh CA, Scheithauer B, Yeung R, et al. Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol 2003; 53: 668-73.
31. Letinic K, Zoncu R, Rakic P. Origin of GABAergic neurons in the human neocortex. Nature 2002; 417: 645-9.
32. McConnell SK. Strategies for the generation of neuronal diversity in the developing central nervous system. J Neurosci 1995; 15: 6987-98.
33. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and characterization of the vesicular GABA transporter. Nature 1997; 389: 870-6.
34. Minelli A, Edwards RH, Manzoni T, Conti F. Postnatal development of the glutamate vesicular transporter VGLUT1 in rat cerebral cortex. Brain Res Dev Brain Res 2003a; 140: 309-14.
35. Minelli A, Alonso-Nanclares L, Edwards RH, DeFelipe J, Conti F. Postnatal development of the vesicular GABA transporter in rat cerebral cortex. Neuroscience 2003b; 117: 337-46.
36. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995; 54: 137-53.
37. Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol 2002; 104: 418-24.
38. Nacher J, Soriano S, Varea E, Molowny A, Ponsoda X, Lopez-Garcia C. CRMP-4 expression in the adult cerebral cortex and other telencephalic areas of the lizard Podarcis hispanica. Brain Res Dev Brain Res 2002; 139: 285-94.
39. Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR. Neurons derived from radial glial cells establish radial units in neocortex. Nature 2001; 409: 714-20.
40. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, et al. Terminology and classification of the cortical dysplasias. Neurology 2004; 62 (Suppl 3): S2-8.
41. Pleasure SJ, Anderson S, Hevner R, Bagri A, Marin O, Lowenstein DH, et al. Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron 2000; 28: 727-40.
42. Roelofs RF, Fischer DF, Houtman SH, Sluijs JA, Van Haren W, Van Leeuwen FW, et al. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia 2005; 52: 289-300.
43. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron 2003; 39: 13-25.
44. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004; 427: 740-4.
45. Seki T. Expression patterns of immature neuronal markers PSA-NCAM, CRMP-4 and NeuroD in the hippocampus of young adult and aged rodents. J Neurosci Res 2002; 70: 327-34.
46. Sisodiya SM, Thom M, Lin WR, Bajaj NP, Cross JH, Harding BN. Abnormal expression of cdk5 in focal cortical dysplasia in humans. Neurosci Lett 2002; 328: 217-20.
47. Terzic J, Saraga-Babic M. Expression pattern of PAX3 and PAX6 genes during human embryogenesis. Int J Dev Biol 1999; 43: 501-8.
48. Thom M, Harding BN, Lin WR, Martinian L, Cross H, Sisodiya SM. Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis. Acta Neuropathol 2003; 105: 561-9.
49. Thom M, Martinian L, Sisodiya SM, Cross JH, Williams G, Stoeber K, et al. Mcm2 labelling of balloon cells in focal cortical dysplasia. Neuropathol Appl Neurobiol 2005; 31: 580-8.
50. Weimann JM, Zhang YA, Levin ME, Devine WP, Brulet P, McConnell SK. Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets. Neuron 1999; 24: 819-31.
51. Wilkinson M, Hume R, Strange R, Bell JE. Glial and neuronal differentiation in the human fetal brain 9-23 weeks of gestation. Neuropathol Appl Neurobiol 1990; 16: 193-204.
52. Yamanouchi H. Activated remodeling and N-methyl-D-aspartate (NMDA) receptors in cortical dysplasia. J Child Neurol 2005; 20: 303-7.
53. Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 2005; 46: 1716-23.
54. Yun K, Fischman S, Johnson J, Hrabe de Angelis M, Weinmaster G, Rubenstein JL. Modulation of the notch signaling by Mash1 and Dlx1/2 regulates sequential specification and differentiation of progenitor cell types in the subcortical telencephalon. Development 2002; 129: 5029-40.
55. Zecevic N. Specific characteristic of radial glia in the human fetal telencephalon. Glia 2004; 48: 27-35.